Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Antibody Production Market Set to Cross $28 Billion by 2026 - Growing Demand for Protein Therapeutics & Rising Adoption of Targeted Immunotherapy - ResearchAndMarkets.com

November 21, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 21, 2019--

The “Global Antibody Production Market Analysis 2019” report has been added to ResearchAndMarkets.com’s offering.

The Antibody Production market is expected to reach $28.11 billion by 2026 growing at a CAGR of 14.2% from 2018 to 2026.

Factors such as an increase in the adoption of targeted immunotherapy improved approval rate of therapeutic antibodies by regulatory authorities, and the rise in R&D expenditure of pharmaceutical and biotechnology companies are driving the market growth. Though, the high cost of primary antibodies restrains the market growth. Moreover, the growing demand for protein therapeutics and growth in adoption of targeted immunotherapy are providing ample growth opportunities for the antibody production market.

Based on the end-user, the pharmaceutical and biotechnology companies segment is going to have a lucrative growth during the forecast period, owing to the large production of therapeutic antibodies and high investment in R&D by companies for drug development.

Key Questions Answered in this Report

  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

Key Topics Covered

1 Market Synopsis

2 Research Outline

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Antibody Production Market, By Process

5.1 Introduction

5.2 Multimodal Chromatography Resins

5.3 Ion Exchange (IEX) Chromatography Resins

5.4 Filtration

5.5 Hydrophobic Interaction Chromatography (HIC) Resins

5.6 Upstream Processing

5.7 Downstream Processing

6 Global Antibody Production Market, By Type

6.1 Introduction

6.2 Monoclonal Antibody

6.3 Polyclonal Antibody

6.4 Other Antibody Types

7 Global Antibody Production Market, By Device

7.1 Introduction

7.2 Bioreactors

7.3 Consumables

7.4 Chromatography

8 Global Antibody Production Market, By Dynamics

8.1 Introduction

8.2 Livestock

8.3 Equine

8.4 Aquaculture

8.5 Poultry

8.6 Porcine

8.7 Other Animals

9 Global Antibody Production Market, By Application

9.1 Introduction

9.2 Infection

9.3 Gastroenterology

9.4 Haematology/Oncology

9.5 Rheumatology

9.6 Cardiology

9.7 Transplantation

10 Global Antibody Production Market, By End User

10.1 Introduction

10.2 Diagnostic Laboratories

10.3 Research & Academic Institutes

10.4 Pharmaceutical and Biotechnology Companies

10.5 Other End Users

11 Global Antibody Production Market, By Geography

11.1 North America

11.2 Europe

11.3 Asia-Pacific

11.4 South America

11.5 Middle East & Africa

12 Strategic Benchmarking

13 Vendors Landscape

13.1 Thermo Fisher Scientific, Inc.

13.2 F. Hoffmann-La Roche Ltd.

13.3 Merck KGaA

13.4 Abbott Laboratories

13.5 Pall Corporation

13.6 GE Healthcare

13.7 Bio-Rad Laboratories Inc.

13.8 Danaher Corporation

13.9 Sartorius AG

13.10 Cellab GmbH

13.11 Fibercell Systems Inc.

13.12 GeneTex Inc.

13.13 Sigma Aldrich Corporation

13.14 INTEGRA Biosciences AG

13.15 Abcam plc

13.16 Enzo Life Sciences Inc.

13.17 Novus Biologicals

For more information about this report visit https://www.researchandmarkets.com/r/9hdzrt

View source version on businesswire.com:https://www.businesswire.com/news/home/20191121005641/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/21/2019 10:06 AM/DISC: 11/21/2019 10:06 AM